Skip to Main Content
Table 2. 
Bayesian Model Comparisons for a Selection of Theoretically Relevant Models in Study 2
Null ModelMain Effect of TreatmentTwo-way Interactions Including Treatment (Atomoxetine vs. Placebo)Three-way Interaction Including Treatment (Atomoxetine vs. Placebo)BF01
Trial Type + CSI + Trial Type × CSI       1.0 
Trial Type + CSI + Trial Type × CSI + Treatment     2.7 
Trial Type + CSI + Trial Type × CSI + Treatment + Treatment × Trial Type   10.5 
Trial Type + CSI + Trial Type × CSI + Treatment + Treatment × CSI   8.1 
Trial Type + CSI + Trial Type × CSI + Treatment + Treatment × Trial Type+ Treatment × CSI   45.5 
Trial Type + CSI + Trial Type × CSI + Treatment + Treatment × Trial Type+ Treatment × CSI + Treatment × Trial Type × CSI 142.9 
Null ModelMain Effect of TreatmentTwo-way Interactions Including Treatment (Atomoxetine vs. Placebo)Three-way Interaction Including Treatment (Atomoxetine vs. Placebo)BF01
Trial Type + CSI + Trial Type × CSI       1.0 
Trial Type + CSI + Trial Type × CSI + Treatment     2.7 
Trial Type + CSI + Trial Type × CSI + Treatment + Treatment × Trial Type   10.5 
Trial Type + CSI + Trial Type × CSI + Treatment + Treatment × CSI   8.1 
Trial Type + CSI + Trial Type × CSI + Treatment + Treatment × Trial Type+ Treatment × CSI   45.5 
Trial Type + CSI + Trial Type × CSI + Treatment + Treatment × Trial Type+ Treatment × CSI + Treatment × Trial Type × CSI 142.9 

The first four columns show the predictors included in each model. The BF01 column shows the Bayes factors of all models compared to the null model. Bayes factors larger than 1.00 mean that the correct RT data were more likely under the null model than under the alternative model.

Close Modal

or Create an Account

Close Modal
Close Modal